JP2023097474A - Oil-in-water emulsion composition - Google Patents
Oil-in-water emulsion composition Download PDFInfo
- Publication number
- JP2023097474A JP2023097474A JP2021213602A JP2021213602A JP2023097474A JP 2023097474 A JP2023097474 A JP 2023097474A JP 2021213602 A JP2021213602 A JP 2021213602A JP 2021213602 A JP2021213602 A JP 2021213602A JP 2023097474 A JP2023097474 A JP 2023097474A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- extract
- water
- water emulsion
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000007764 o/w emulsion Substances 0.000 title claims abstract description 18
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 57
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 28
- 239000011570 nicotinamide Substances 0.000 claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 15
- 239000000216 gellan gum Substances 0.000 claims abstract description 15
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 15
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 6
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 5
- 230000002087 whitening effect Effects 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 8
- 229960000271 arbutin Drugs 0.000 claims description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 4
- 229960000401 tranexamic acid Drugs 0.000 claims description 4
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 abstract description 27
- 238000003860 storage Methods 0.000 abstract description 7
- 239000000839 emulsion Substances 0.000 abstract description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 239000013078 crystal Substances 0.000 description 30
- 238000011156 evaluation Methods 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- -1 sorbitol fatty acid ester Chemical class 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 230000003796 beauty Effects 0.000 description 10
- 239000000686 essence Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 229960001631 carbomer Drugs 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- CZKPBCHPLNOUSJ-UHFFFAOYSA-N 1-octadecoxyperoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOOOCCCCCCCCCCCCCCCCCC CZKPBCHPLNOUSJ-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 241000013298 Alpinia <beetle> Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 235000005206 Hibiscus Nutrition 0.000 description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940039585 comfrey leaf extract Drugs 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 229940031766 diethanolamine cetyl phosphate Drugs 0.000 description 2
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 2
- 229940071085 lauroyl glutamate Drugs 0.000 description 2
- 229940100485 methyl gluceth-10 Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALYQTSXGWBNEQC-VWMHFEHESA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;octadecanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.CCCCCCCCCCCCCCCCCC(O)=O ALYQTSXGWBNEQC-VWMHFEHESA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HJDITXMCJQRQLU-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]acetate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N(C)CC(O)=O HJDITXMCJQRQLU-UHFFFAOYSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- 244000056974 Adansonia digitata Species 0.000 description 1
- 235000003320 Adansonia digitata Nutrition 0.000 description 1
- 235000003319 Adansonia gregorii Nutrition 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- SKQOTPRMPUYWSH-FQEVSTJZSA-N CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O SKQOTPRMPUYWSH-FQEVSTJZSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 240000003173 Drymaria cordata Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000008681 Phellinus linteus extract Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000790234 Sphingomonas elodea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 241001534869 Terminalia Species 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 1
- 229950001798 amiphenazole Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- CEBAWORGZDCFQS-UHFFFAOYSA-N butylcarbamic acid 1-iodoprop-1-yne Chemical compound C(#CC)I.C(CCC)NC(O)=O CEBAWORGZDCFQS-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- CNXJITYCNQNTBD-UHFFFAOYSA-L dipotassium;hexadecyl phosphate Chemical compound [K+].[K+].CCCCCCCCCCCCCCCCOP([O-])([O-])=O CNXJITYCNQNTBD-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940108690 glucosyl hesperidin Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000003702 image correction Methods 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000015206 pear juice Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229940109529 pomegranate extract Drugs 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 1
- ZNOZEKFDBJRBMI-UHFFFAOYSA-M sodium;4-(2-ethylhexoxy)-4-oxo-3-sulfobutanoate Chemical compound [Na+].CCCCC(CC)COC(=O)C(S(O)(=O)=O)CC([O-])=O ZNOZEKFDBJRBMI-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000008522 spreadable oils and fats Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940071136 stearoyl glutamate Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229940095479 sweet marjoram extract Drugs 0.000 description 1
- 229940059959 tabebuia impetiginosa bark extract Drugs 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、ベタツキがない使用感触に優れ、かつ結晶析出抑制効果に優れ、高温での乳化安定性の良好でさらに優れた美白効果を有する水中油型乳化組成物に関するものである。 The present invention relates to an oil-in-water emulsified composition which has an excellent non-sticky feeling in use, an excellent effect of suppressing crystal precipitation, good emulsification stability at high temperatures, and an excellent whitening effect.
近年、化粧品の製品コンセプトとして、加齢やストレス、紫外線や空気の乾燥などにより、シミやシワ、たるみ、色素沈着等を改善することを目的とした製品が多く発売されている。特にシミや色素沈着などの皮膚色の変化は、加齢が進んだ印象をあたえるため改善を望む人は多い。効果成分としてニコチン酸アミドは、色素細胞から表皮細胞へのメラニンの転送を阻害することにより色素沈着を防止する美白効果が知られている(非特許文献1)。 In recent years, as a product concept for cosmetics, many products aimed at improving age spots, wrinkles, sagging, pigmentation, etc. due to aging, stress, ultraviolet rays, air dryness, etc. have been released. In particular, many people want to improve skin color changes such as spots and pigmentation because they give the impression that aging has progressed. Nicotinamide as an active ingredient is known to have a whitening effect of preventing pigmentation by inhibiting transfer of melanin from pigment cells to epidermal cells (Non-Patent Document 1).
しかしながら、ニコチン酸アミドを多く配合することでベタツキやキシミなどが発生し、良好な使用感触が得られないということが知られている(特許文献1)。特にニコチン酸アミドを1質量%以上配合した皮膚外用組成物の場合には、中身が口部や、キャップに付着した後乾燥した場合、容器側面に付着した時などでニコチン酸アミドの結晶が析出することが知られている(特許文献2、特許文献3)。 However, it is known that when a large amount of nicotinic acid amide is blended, stickiness, creaking, etc. occur, and a good feel during use cannot be obtained (Patent Document 1). In particular, in the case of an external skin composition containing 1% by mass or more of nicotinic acid amide, crystals of nicotinic acid amide precipitate when the content dries after adhering to the mouth or cap, or when adhering to the side of the container. It is known to do (Patent Document 2, Patent Document 3).
これに対し、特許文献1では、特定の分枝鎖炭化水素、特定の高展性油を併用することで、ニコチン酸アミドを多量に配合した場合のベタツキを抑えられたのだが、中身が口部やキャップに付着して結晶が析出しスムーズな容器の開閉を妨げる場合があった。他には、水中油型乳化組成物において、直鎖脂肪酸とポリエチレングリコールとのエステルを乳化剤として用いて、ワセリンを配合するという対応をおこなうことで、1%以上のニコチン酸アミドを配合しても刺激感・べたつきがなく使用感触に優れ、かつ結晶抑制効果に優れた水中油型乳化組成物を得ることが報告されている(特許文献4)。しかしながら、特許文献4では総合的に良好な皮膚外用組成物が得られているものの、ワセリンを必須とする水中油型乳化物に限定されており充分な汎用性を持つとは言い難い。特許文献2では、特定のカチオン配合ポリマーを配合することにより結晶析出は改善されるが、ベタツキが増し、使用感触の良くないものであった。 On the other hand, in Patent Document 1, by using a specific branched-chain hydrocarbon and a specific highly spreadable oil in combination, the stickiness when a large amount of nicotinic acid amide is blended can be suppressed, but the content is mouth-watering. In some cases, crystals adhered to the parts and caps and precipitated, hindering smooth opening and closing of the container. In addition, in the oil-in-water emulsion composition, by using an ester of a linear fatty acid and polyethylene glycol as an emulsifier and adding vaseline, 1% or more of nicotinic acid amide can be added. It has been reported to obtain an oil-in-water emulsified composition that is free from irritation and stickiness, has an excellent feeling in use, and has an excellent effect of inhibiting crystallization (Patent Document 4). However, in Patent Document 4, although a comprehensively good composition for external use on the skin is obtained, it is limited to an oil-in-water emulsion essentially containing petrolatum, and it is difficult to say that it has sufficient versatility. In Patent Document 2, crystal precipitation is improved by blending a specific cation-containing polymer, but the stickiness increases and the feeling of use is not good.
一方、皮膚外用剤の増粘剤として配合される水溶性高分子としては、カルボマーなどのアクリル酸系増粘剤が挙げられるが、一般に耐塩性に乏しく電解質の種類によっては、著しい粘度低下や凝集をおこすため安定性不良の原因となることはよく知られており様々なアプローチで技術開発されている。例えば、特許文献5のように高温での安定性を得るために、特定の界面活性剤(ポリオキシエチレン付加型ヒマシ油とポリオキシエチレン付加型ソルビット脂肪酸エステル)を用いるといった技術が開示されている。さらに気候の温暖化で夏場の室温が上昇しているため、今まで以上に耐高温性を高めた処方が必要とされている。具体的には、今までであれば50℃以上での安定性で十分と思われていたが、最近では60℃程度までの保管安定性確認が必要な場合がある。一般的に保管温度を上げることで低粘度化が進み著しく安定性が低下する。つまり低温での保管より、より高温での保管の方が保管安定性に対する負荷が高い。 On the other hand, as a water-soluble polymer that is blended as a thickener for external skin preparations, acrylic acid-based thickeners such as carbomer can be mentioned, but they generally have poor salt tolerance, and depending on the type of electrolyte, they can significantly reduce viscosity or aggregate. It is well known that it causes poor stability due to the occurrence of For example, Patent Document 5 discloses a technique of using specific surfactants (polyoxyethylene-added castor oil and polyoxyethylene-added sorbitol fatty acid ester) to obtain stability at high temperatures. . Furthermore, since the room temperature in the summertime is rising due to climate warming, there is a need for formulations with higher resistance to high temperatures than ever before. Specifically, until now, it was thought that stability at 50°C or higher was sufficient, but in recent years, confirmation of storage stability up to about 60°C may be necessary. In general, increasing the storage temperature causes the viscosity to decrease and the stability to decrease significantly. In other words, storage at a higher temperature imposes a higher load on storage stability than storage at a lower temperature.
以上のことにより、ニコチン酸アミドを配合することで、優れた美白効果を発揮することができるが、ベタツキがなく使用感触に優れ、かつ結晶が析出しない、さらに高温でも乳化安定性の良好な水中油型乳化組成物は知られていない状況である。 From the above, by blending nicotinic acid amide, it is possible to exhibit an excellent whitening effect, but it is not sticky and has an excellent feel when used, does not precipitate crystals, and has good emulsification stability even at high temperatures. Oil-type emulsified compositions are not yet known.
本発明は、ニコチン酸アミドを高配合した場合に生じるベタツキ等の使用感、使用・保管時に生じる析出を改善し、さらに充分な高温での乳化安定性および優れた美白効果を有することを課題とする。
An object of the present invention is to improve the feel of use such as stickiness that occurs when a large amount of nicotinic acid amide is blended, to improve precipitation that occurs during use and storage, and to have sufficient emulsion stability at high temperatures and excellent whitening effects. do.
かかる実情を鑑み、本発明者は、上記課題を解決するために鋭意研究を重ねた結果、
次の成分(A)~(E);
(A)ニコチン酸アミド:1~10質量%
(B)アニオン性界面活性剤
(C)20℃で固体状の高級アルコール
(D)ジェランガム
(E)多価アルコール:5~25質量%
を含む水中油型乳化組成物が上記の課題を解決できることを見出し、本発明を完成するに至った。
In view of this situation, the inventors of the present invention, as a result of extensive research to solve the above problems,
the following components (A) to (E);
(A) Nicotinamide: 1 to 10% by mass
(B) Anionic surfactant (C) Higher alcohol solid at 20°C (D) Gellan gum (E) Polyhydric alcohol: 5 to 25 mass%
The inventors have found that an oil-in-water emulsion composition containing can solve the above problems, and have completed the present invention.
本発明はさらに成分(E)と成分(A)の配合質量割合が、(E)/(A)≧2である水中油型乳化組成物に関するものである。 The present invention further relates to an oil-in-water emulsion composition in which the blending mass ratio of component (E) and component (A) is (E)/(A)≧2.
本発明はさらに(F)水溶性美白剤を配合することができる。 The present invention can further contain (F) a water-soluble whitening agent.
本発明は(F)水溶性美白剤がアスコルビン酸誘導体及びその塩、トラネキサム酸、アルブチンから選ばれた1種以上の水溶性美白剤である水中油型乳化組成物である。
The present invention is (F) an oil-in-water emulsion composition in which the water-soluble whitening agent is one or more water-soluble whitening agents selected from ascorbic acid derivatives and salts thereof, tranexamic acid, and arbutin.
本発明の水中油型乳化組成物は、ベタツキがなく使用感触に優れ、かつ結晶析出抑制効果と高温での乳化安定性および美白効果に優れた効果を有するものである。 The oil-in-water emulsified composition of the present invention is non-sticky and has an excellent feel in use, and has excellent effects of suppressing crystal precipitation, high-temperature emulsion stability, and whitening effect.
以下、本発明について詳細に説明する。なお、本明細書において、「~」はその前後の数値を含む範囲を意味するものとする。また、%で表記する数値は、特に記載した場合を除き、質量を基準にした値である。 The present invention will be described in detail below. In this specification, "-" shall mean a range including numerical values before and after it. In addition, numerical values expressed in % are values based on mass unless otherwise specified.
本発明における成分(A)ニコチン酸アミド(C6H6NO/分子量:122.12)は、ニコチン酸(ビタミンB3、ナイアシン)の水溶性のアミド化合物である。本発明では、米ぬかから抽出したものや、合成したものを配合することができる。具体的には、第15改正日本薬局方2008に収載されているものを用いることが出来る。溶状においては、水やエタノールに易溶で、ジエチルエーテルには難溶である。多価アルコールや油剤にも溶けにくいことが知られている。 Component (A) nicotinic acid amide (C6H6NO/molecular weight: 122.12) in the present invention is a water-soluble amide compound of nicotinic acid (vitamin B3, niacin). In the present invention, one extracted from rice bran or one synthesized can be blended. Specifically, those listed in the Japanese Pharmacopoeia 2008, 15th Edition can be used. It is readily soluble in water and ethanol, and sparingly soluble in diethyl ether. It is known to be difficult to dissolve in polyhydric alcohols and oils.
成分(A)の配合量は、1~10質量%(以下、単に「%」と略す)である。より好ましくは2~8%である。成分(A)の配合量がこの範囲であるとシミや色素沈着の改善効果が得られる。尚、10%を超えて配合しても効果面では頭打ちの傾向にあり、加えて組成物中の水分が蒸発した際に結晶析出する恐れがある。 The blending amount of component (A) is 1 to 10% by mass (hereinafter simply abbreviated as “%”). More preferably 2 to 8%. When the amount of the component (A) is within this range, an effect of improving stains and pigmentation can be obtained. Even if the content exceeds 10%, the effect tends to reach a peak, and in addition, crystals may precipitate when the water in the composition evaporates.
本発明における(B)アニオン性界面活性剤としては、例えば、ラウリン酸ナトリウム、パルミチン酸カリウム、ステアリン酸アルギニン等の炭素数12~24の脂肪酸を由来とする脂肪酸塩;ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等のアルキル硫酸エステル塩;ポリオキシエチレンラウリル硫酸トリエタノールアミン等のアルキルエーテル硫酸エステル塩;ラウロイルサルコシンナトリウム等のN-アシルサルコシン塩;N-ステアロイル-N-メチルタウリンナトリウム、N-ミリストイル-N-メチルタウリンナトリウム等の脂肪酸アミドスルホン酸塩;モノセチルリン酸カリウム等のアルキルリン酸塩;ポリオキシエチレンオレイルエーテルリン酸ナトリウム、ポリオキシエチレンステアリルエーテルリン酸ナトリウム等のポリオキシエチレンアルキルエーテルリン酸塩;ジ-2-エチルヘキシルスルホコハク酸ナトリウム等の長鎖スルホコハク酸塩;N-ラウロイルグルタミン酸モノナトリウム、N-ステアロイル-L-グルタミン酸ナトリウム、N-ステアロイル-L-グルタミン酸アルギニン、N-ステアロイルグルタミン酸ナトリウム、N-ミリストイル-L-グルタミン酸ナトリウム等の長鎖N-アシルグルタミン酸塩などが挙げられる。これらのうち、アルキルリン酸塩、長鎖N-アシルグルタミン酸塩が好ましく、セチルリン酸塩、ステアロイルグルタミン酸塩がより好ましい。 Examples of (B) anionic surfactants in the present invention include fatty acid salts derived from fatty acids having 12 to 24 carbon atoms, such as sodium laurate, potassium palmitate, and arginine stearate; sodium lauryl sulfate, potassium lauryl sulfate; Alkyl sulfate ester salts such as polyoxyethylene lauryl sulfate triethanolamine; Alkyl ether sulfate ester salts such as triethanolamine lauroyl sarcosinate; N-acylsarcosine salts such as sodium lauroyl sarcosinate; fatty acid amide sulfonates such as sodium methyltaurate; alkyl phosphates such as potassium monocetyl phosphate; polyoxyethylene alkyl ether phosphates such as sodium polyoxyethylene oleyl ether phosphate and sodium polyoxyethylene stearyl ether phosphate; -long-chain sulfosuccinates such as sodium 2-ethylhexyl sulfosuccinate; monosodium N-lauroyl glutamate, sodium N-stearoyl-L-glutamate, arginine N-stearoyl-L-glutamate, sodium N-stearoyl glutamate, N-myristoyl- long-chain N-acylglutamates such as sodium L-glutamate; Among these, alkyl phosphate and long-chain N-acyl glutamate are preferred, and cetyl phosphate and stearoyl glutamate are more preferred.
成分(B)の配合量は、特に限定されないが、0.1~3%であることが望ましく、より好ましくは、0.3~1%である。 The amount of component (B) to be blended is not particularly limited, but is desirably 0.1 to 3%, more preferably 0.3 to 1%.
本発明における(C)20℃で固体状の高級アルコールの炭素数は特に限定されないが、炭素数16以上の直鎖状飽和アルコールが好ましい。例えば、セチルアルコール、ステアリルアルコール、ベヘニルアルコール等が挙げられる。 The number of carbon atoms in the (C) higher alcohol that is solid at 20° C. in the present invention is not particularly limited, but linear saturated alcohols having 16 or more carbon atoms are preferred. Examples include cetyl alcohol, stearyl alcohol, behenyl alcohol and the like.
成分(C)の配合量は、特に限定されないが、0.2~5%であることが望ましく、より好ましくは、0.5~3%である。 The amount of component (C) is not particularly limited, but is preferably 0.2 to 5%, more preferably 0.5 to 3%.
本発明における(D)ジェランガムは、ブドウ糖を基質として細菌Pseudomonaselodeaの純粋培養によって得られるヘテロポリサッカライドであり、化粧料分野で一般的に使用されているものであれば、ネイティブ型ジェランガムでも、脱アシル型ジェランガムでも特に制限されずに用いることができる。これらの中でもネイティブ型ジェランガムを用いることが好ましい。 (D) gellan gum in the present invention is a heteropolysaccharide obtained by pure culture of the bacterium Pseudomonaselodea using glucose as a substrate. Gellan gum can also be used without particular limitations. Among these, it is preferable to use native gellan gum.
成分(D)の配合量は、特に限定されないが、0.01~1%であることが望ましく、より好ましくは、0.02~0.5%である。配合量が1%を超えるとべたつく場合がある。市販のケルコゲル、ケルコゲルHM(いずれもCPケルコ社)等を用いることもできる。 The amount of component (D) is not particularly limited, but is preferably 0.01 to 1%, more preferably 0.02 to 0.5%. If the blending amount exceeds 1%, stickiness may occur. Commercially available Kelcogel and Kelcogel HM (both from CP Kelco) can also be used.
本発明における成分(E)多価アルコールは、成分(A)を溶解させ結晶析出を抑制するために配合される。多価アルコールだけでは、結晶析出抑制効果はほとんどないが(D)ジェランガムと併用することで良好な結果が得られる。成分(E)は、外用組成物に一般に用いられるものであれば、特に制限されないが、例えば、2価のアルコールである1,3ブチレングリコールのようなアルカンジオール類でもよく、3価以上のアルコールであるグリセリンやジグリセリン、水酸基が多い糖類や糖アルコールでもよく、必要に応じて一種または二種以上を適宜選択して用いることができる。 Component (E) polyhydric alcohol in the present invention is blended to dissolve component (A) and suppress crystal precipitation. A polyhydric alcohol alone has almost no effect of suppressing crystal precipitation, but good results can be obtained by using it together with (D) gellan gum. Component (E) is not particularly limited as long as it is commonly used in external compositions. Glycerin, diglycerin, saccharides and sugar alcohols with many hydroxyl groups may be used, and if necessary, one or more of them can be appropriately selected and used.
成分(E)の配合量は、多量の多価アルコールを配合すると使用感的にベタツキが発生しやすくなるため25%以下が望ましい。一方、成分(A)を溶解させ結晶析出を抑制するために、成分(E)は組成物全体の5%以上含まれる必要があり、さらには成分(A)に対し2倍量以上配合されているとより好ましく結晶析出を抑制できる。 The blending amount of component (E) is desirably 25% or less, because if a large amount of polyhydric alcohol is blended, stickiness tends to occur in terms of feel during use. On the other hand, in order to dissolve component (A) and suppress crystal precipitation, component (E) must be contained in an amount of 5% or more of the entire composition, and more than twice the amount of component (A). Crystal precipitation can be suppressed more preferably.
本発明の水中油型乳化組成物は、上記成分(A)~(E)を配合することにより、シミや色素沈着などの皮膚色の変化を改善すると共に、刺激感・ベタツキがない使用感触に優れ、かつ結晶析出抑制効果、および高温の乳化安定性に優れた水中油型乳化組成物にすることが可能となる。 The oil-in-water emulsion composition of the present invention improves skin color changes such as spots and pigmentation by blending the above components (A) to (E), and provides a feeling of use without irritation or stickiness. It is possible to obtain an oil-in-water emulsified composition that is excellent, has an excellent effect of suppressing crystal precipitation, and has excellent high-temperature emulsification stability.
本発明はさらに、(F)水溶性美白剤を配合することができる。水溶性美白剤は特に限定されないが、アスコルビン酸誘導体及びその塩、トラネキサム酸、アルブチンから選ばれた1種以上の水溶性美白剤を配合することで美白効果を増強することができる。 The present invention can further contain (F) a water-soluble whitening agent. The water-soluble whitening agent is not particularly limited, but the whitening effect can be enhanced by adding one or more water-soluble whitening agents selected from ascorbic acid derivatives and salts thereof, tranexamic acid, and arbutin.
本発明の水中油型乳化組成物には、上記成分の他に、本発明の効果を妨げない範囲で通常の水中油型乳化組成物に配合される任意成分、すなわち、上記必須成分以外の、水性成分、油剤、粉体、皮膜形成剤、界面活性剤、油溶性ゲル化剤、有機変性粘土鉱物、樹脂、着色剤、紫外線吸収剤、防腐剤、抗菌剤、香料、酸化防止剤、pH調整剤、キレート剤、美容成分等を配合することができる。 In addition to the above components, the oil-in-water emulsion composition of the present invention includes optional components that are blended in ordinary oil-in-water emulsion compositions within a range that does not hinder the effects of the present invention, that is, other than the above essential components, Aqueous component, oil, powder, film-forming agent, surfactant, oil-soluble gelling agent, organically modified clay mineral, resin, colorant, ultraviolet absorber, preservative, antibacterial agent, fragrance, antioxidant, pH adjustment agents, chelating agents, cosmetic ingredients and the like can be blended.
本発明の水中油型乳化組成物は、他の成分との併用により種々の剤型とすることもできる。具体的には、液状、ゲル状、ペースト状、クリーム状、固形状、シート状等、種々の剤型にて実施することができる。 The oil-in-water emulsion composition of the present invention can be used in combination with other ingredients to form various dosage forms. Specifically, various dosage forms such as liquid, gel, paste, cream, solid, and sheet can be used.
本発明の水中油型乳化組成物は、化粧料の他、特に抗老化効果を期待してニコチン酸アミドを高配合する医薬部外品を調製するのに適している。具体的には、例えば化粧水、乳液、クリーム、美容液、マッサージ化粧料、パック化粧料、ハンドクリーム、ボディローション、ボディクリームなどに用いることができる。その使用方法は、手や指、コットンで使用する、不織布等に含浸させて使用する、噴射剤を用いてエアゾール化させるなどの方法が挙げられる。 INDUSTRIAL APPLICABILITY The oil-in-water emulsified composition of the present invention is suitable for preparing quasi-drugs containing a large amount of nicotinic acid amide in anticipation of an anti-aging effect, in addition to cosmetics. Specifically, for example, it can be used in lotions, milky lotions, creams, beauty essences, massage cosmetics, pack cosmetics, hand creams, body lotions, body creams, and the like. The method of use includes methods such as using with hands, fingers, cotton, impregnating non-woven fabrics, and aerosolizing with a propellant.
本発明について以下に実施例を挙げてさらに詳述するが、本発明はこれによりなんら限定されるものではない。配合量は特記しない限り、その成分が配合される系に対する質量%で示す。 EXAMPLES The present invention will be described in more detail below with reference to Examples, but the present invention is not limited to these. Unless otherwise specified, the blending amount is shown in % by mass relative to the system in which the component is blended.
実験1:増粘剤に与えるニコチン酸アミドの影響
1%カルボマーゲルを用いて、ニコチン酸アミド配合量による粘度変化を確認した。結果を表1に示す。
(実験方法)
(1):1%カルボマー水溶液を、水酸化カリウムを用いてpH6.5に調整して、ゲル化させ1%カルボマーゲルとした。
(2):上記1%カルボマーゲルに所定量のニコチン酸アミドを添加し、均一に溶解した後、20℃で4時間放置し粘度を測定した。粘度低下度は数1の式に基づいて算出した。
(測定条件)
測定機器:東機産業社製 VISCOTESTER TVB-10
測定条件:ローター M3、回転数 12rpm、60秒後、20℃環境下
Experiment 1: Effect of nicotinamide on thickening agent Using 1% carbomer gel, the change in viscosity depending on the amount of nicotinamide blended was confirmed. Table 1 shows the results.
(experimental method)
(1): A 1% carbomer aqueous solution was adjusted to pH 6.5 using potassium hydroxide and gelled to form a 1% carbomer gel.
(2): A predetermined amount of nicotinic acid amide was added to the above 1% carbomer gel, dissolved uniformly, allowed to stand at 20°C for 4 hours, and the viscosity was measured. The degree of decrease in viscosity was calculated based on the formula (1).
(Measurement condition)
Measuring instrument: VISCOTESTER TVB-10 manufactured by Toki Sangyo Co., Ltd.
Measurement conditions: Rotor M3, rotation speed 12 rpm, after 60 seconds, under 20°C environment
(考察)
ニコチン酸アミドの配合量が1%に達しないような低濃度領域では、粘度低下が少なかった。ニコチン酸アミドは電解質であるが、化粧料の増粘安定剤として汎用されているカルボマーのような、電解質に敏感な水溶性高分子ゲルの粘度低下に対して比較的影響が少ないことが示唆された。しかし配合量が1%を超えて高濃度になった場合には、明らかな粘度低下が起こることが本実験で示されている。そのため分離などの安定性不良が起こりやすくなることが懸念された。
尚、塩化ナトリウムを用いて同様の試験を行った場合は以下のとおりであった。
1%カルボマーゲルに代表的電解質である塩化ナトリウムを0.1%加えた時の粘度は、35.3mPa.s(測定条件:ローター M1、回転数 60rpm、60秒後、20℃環境下)粘度低下度=99.4%
(Discussion)
In the low-concentration range where the amount of nicotinic acid amide blended did not reach 1%, the decrease in viscosity was small. Although nicotinamide is an electrolyte, it is suggested that it has relatively little effect on the viscosity reduction of water-soluble polymer gels that are sensitive to electrolytes, such as carbomer, which is widely used as a thickening stabilizer for cosmetics. rice field. However, this experiment shows that when the blending amount exceeds 1% and the concentration becomes high, a clear decrease in viscosity occurs. Therefore, there was a concern that poor stability such as separation is likely to occur.
Incidentally, when the same test was conducted using sodium chloride, the results were as follows.
When 0.1% sodium chloride, which is a typical electrolyte, is added to 1% carbomer gel, the viscosity is 35.3 mPa.s. s (measurement conditions: rotor M1, rotation speed 60 rpm, after 60 seconds, under 20°C environment) Viscosity reduction = 99.4%
本発明品1~12及び比較品1~8:水中油型乳液
下記表2に示す処方の水中油型乳化クリームを調製し、ベタツキのなさ、結晶析出抑制効果、高温での乳化安定性について下記の方法により評価した。また、実施例1、実施例2、比較例8は美白効果を評価した。その結果も併せて表2に示す。
Products 1 to 12 of the present invention and comparative products 1 to 8: Oil-in-water emulsion An oil-in-water emulsion cream having the formulation shown in Table 2 below was prepared, and the absence of stickiness, the effect of suppressing crystal precipitation, and the emulsification stability at high temperature were evaluated as follows. was evaluated by the method of Moreover, Example 1, Example 2, and Comparative Example 8 evaluated the whitening effect. The results are also shown in Table 2.
(評価項目)
ベタツキのなさ
結晶析出抑制効果
高温での乳化安定性
美白効果
(Evaluation item)
Non-sticky Crystal precipitation suppression effect Emulsification stability at high temperature Whitening effect
(評価方法)
[ベタツキのなさの官能評価方法]
20代~40代の女性で官能評価の訓練を受けた、専門パネラーを10名にて評価を行った。各試料について専門パネラーが皮膚に塗布した後の直後のベタツキを評価した。
下記絶対評価にて5段階評価をおこない、その平均値を算出し、下記4段階判定基準により判定した。
(Evaluation method)
[Method for sensory evaluation of lack of stickiness]
Evaluation was performed by 10 professional panelists who were women in their 20s to 40s who had undergone sensory evaluation training. Each sample was evaluated for stickiness immediately after application to the skin by expert panelists.
Five-level evaluation was performed in the following absolute evaluation, the average value was calculated, and evaluation was made according to the following four-level evaluation criteria.
[ベタツキのなさの評価方法]
(点数):(評価)
5点:ベタツキを感じない
4点:ほとんどベタツキを感じない
3点:ややベタツキを感じる
2点:ベタツキを感じる
1点:非常にベタツキを感じる
4段階判定基準
(判定):(評点の平均点)
◎ :4点以上
○ :3点以上~4点未満
△ :2点以上~3点未満
× :2点未満
[Evaluation method for non-stickiness]
(score): (evaluation)
5 points: Does not feel sticky
4 points: hardly feels sticky
3 points: Slightly sticky
2 points: feels sticky
1 point: Feels very sticky 4-step judgment criteria (Judgment): (Average score)
◎ : 4 points or more
○: 3 points or more to less than 4 points
△: 2 points or more to less than 3 points
×: Less than 2 points
[結晶析出抑制効果の評価方法]
結晶析出抑制効果の評価については、滅菌シャーレ(ポリスチレン製:90mmΦ×15mm)に試料4gを底面に塗布し、30℃インキュベーター内に解放状態(蓋をしない状態)で24時間静置した。その後、各試料を顕微鏡観察した。結晶析出状態は、光学顕微鏡40倍にて偏光フィルターを用いて観察した。
<判定基準>
(判定):(評価)
◎ :結晶の析出がない。
○ :わずかに結晶の析出がみられる。
× :結晶の析出が明らかに見られる。
[Evaluation method of crystal precipitation suppression effect]
For the evaluation of the effect of suppressing crystal precipitation, 4 g of the sample was applied to the bottom of a sterilized petri dish (made of polystyrene: 90 mmΦ×15 mm) and allowed to stand in an open state (with no lid) in a 30° C. incubator for 24 hours. Each sample was then observed under a microscope. The state of crystal precipitation was observed with a 40x optical microscope using a polarizing filter.
<Judgment Criteria>
(judgment): (evaluation)
A: No precipitation of crystals.
◯: Slight precipitation of crystals is observed.
x: Precipitation of crystals is clearly observed.
[高温での乳化安定性の評価方法]
(乳化安定性の評価)
実施例1~12、比較例1~8の各試料を、60℃の温度条件下に2週間保存し、外観変化を目視により観察し、下記3段階の判定基準により判定した。
3段階判定基準
(判定):(評価結果)
◎ :変化なし、均一:非常に良好
○ :1週間は変化がないが、2週間後には分離が認められる:良好
× :1週間以内に分離が認められる:不良
[Evaluation method for emulsion stability at high temperature]
(Evaluation of emulsion stability)
The samples of Examples 1 to 12 and Comparative Examples 1 to 8 were stored under a temperature condition of 60° C. for 2 weeks, visually observed for changes in appearance, and judged according to the following 3-step judgment criteria.
Three-stage judgment criteria (judgment): (evaluation result)
◎: no change, uniform: very good ○: no change in 1 week, separation observed after 2 weeks: good ×: separation observed within 1 week: poor
[美白効果の評価方法]
30代~50代の女性20名を2群に分け、第1群は半顔にニコチン酸アミドと水溶性美白剤を配合した試料(実施例1)、もう一方にはプラセボ(比較例8)を1日2回塗布、第2群は半顔にニコチン酸アミドを配合した試料(実施例2)、もう一方にはプラセボを1日2回塗布で8週間連用してもらった。連用前後の顔の正面および半顔を、顔写真専用撮影ミニスタジオVISIA―CR(CANFIELD社製)を用いて撮影した。撮影は、被験者の額部に画像補整用カラーチャートを貼付した状態で写真撮影を行い、Photoshop(アドビ システムズ インコーポレイテッド)(登録商標)の機能を用いてカラーチャートのホワイトバランスが一定となるように各撮影画像を補正することで解析用画像を得た。連用前後での解析用画像比較をもとに、「美白効果」について化粧品評価専門パネル3名で評価した。評価基準は、以下の通りである。下記5段階評価基準により評点を付してもらい、全パネルの評点の平均値を下記4段階評価基準に従って判定した。
(評点)
5点:美白効果に特に優れる
4点:美白効果に優れる
3点:美白効果がある
2点:美白効果がわずかにある
1点:美白効果がない
結果は、平均値から、下記基準に基づき示した。
(評価基準)
◎:平均点が4点以上
○:平均点が3点以上4点未満
△:平均点が2点以上3点未満
×:平均点が2点未満
[Evaluation method for whitening effect]
Twenty women in their 30s to 50s were divided into two groups. The first group was a sample containing nicotinic acid amide and a water-soluble whitening agent on the half face (Example 1), and the other was a placebo (Comparative Example 8). was applied twice a day, the second group was a sample in which nicotinic acid amide was blended on the half face (Example 2), and the other group was asked to apply a placebo twice a day for 8 weeks. The front and half faces of the face before and after continuous use were photographed using a facial photography mini studio VISIA-CR (manufactured by CANFIELD). Photographs were taken with the color chart for image correction attached to the subject's forehead, and the white balance of the color chart was adjusted using Photoshop (Adobe Systems Incorporated) (registered trademark) functions. Images for analysis were obtained by correcting each photographed image. Based on comparison of images for analysis before and after continuous use, the "whitening effect" was evaluated by a panel of three cosmetics evaluation specialists. Evaluation criteria are as follows. The samples were rated according to the following 5-grade evaluation criteria, and the average score of all the panels was determined according to the following 4-grade evaluation criteria.
(Rating)
5 points: particularly excellent whitening effect 4 points: excellent whitening effect 3 points: whitening effect 2 points: slight whitening effect 1 point: no whitening effect Results are shown based on the following criteria from the average values. rice field.
(Evaluation criteria)
◎: Average score of 4 or more ○: Average score of 3 or more and less than 4 △: Average score of 2 or more and less than 3 ×: Average score of less than 2
ステアロイルグルタミン酸ナトリウム *1 アミソフト HS―11P 味の素ヘルシーサプライ社製
セチルリン酸カリウム *2 AMPHISOL K DSM ニュートリション社製
ジェランガム *3 ケルコゲルHM CPケルコ社製
(なお、以下に記載する*1、*2および*3はそれぞれ同一のものを指す)
Sodium Stearoyl Glutamate *1 Amisoft HS-11P Ajinomoto Healthy Supply Potassium Cetyl Phosphate *2 AMPHISOL K DSM Nutrition Gellan Gum *3 Kelco Gel HM CP Kelco (Note that *1, *2 and *3 described below are each point to the same thing)
製造方法
(a):1~12を70℃で均一に溶解混合する。
(b):25の精製水に順次その他成分を加え、70℃で均一に溶解混合する。
(c):(b)に(a)を添加し70℃で乳化する。
(d):40℃まで攪拌冷却して目的の組成物とする。
Production method (a): 1 to 12 are uniformly dissolved and mixed at 70°C.
(b): Other ingredients are added to the purified water of 25 in sequence, and dissolved and mixed uniformly at 70°C.
(c): (a) is added to (b) and emulsified at 70°C.
(d): Stir and cool to 40° C. to obtain the desired composition.
表2の結果から明らかなように、本発明品の実施例1~12の水中油型乳化組成物は、比較例1~8に比べ、ベタツキのなさ、結晶析出抑制効果、高温での乳化安定性の全てにおいて良好な結果が得られた。また、実施例1、実施例2の美白効果が認められ、特にニコチン酸アミドに加えて水溶性美白剤を配合した実施例1は優れた効果を確認した。
一方、(B)アニオン性界面活性剤を配合していない比較品1、2は経時安定性試験にて3日以内に顕著な分離が見られ、ベタツキを感じる使用感となった。(C)20℃で固体状の高級アルコールを配合していない比較例3、および20℃で液体状の分岐鎖飽和アルコールであるイソステアリルアルコールを使用した比較例4は、経時安定性試験にて翌日までに顕著な分離が見られた。(D)ジェランガムを配合していない比較例5は結晶析出が確認され、さらに3日以内に顕著な分離が見られた。(D)ジェランガムの代わりに汎用的な増粘剤であるキサンタンガムを用いた比較例6も、結晶析出、さらに1週間以内に顕著な分離が見られた。(E)多価アルコールの代わりに一価のアルコールであるエタノールを配合した比較例7については、結晶析出を生じた。また、ニコチン酸アミドを配合していない比較例8については、美白効果をほとんど確認できなかった。
As is clear from the results in Table 2, the oil-in-water emulsion compositions of Examples 1 to 12 of the products of the present invention are less sticky, less effective in suppressing crystal precipitation, and more stable at high temperatures than in Comparative Examples 1 to 8. Good results were obtained in all aspects. In addition, the whitening effects of Examples 1 and 2 were observed, and particularly excellent effects were confirmed in Example 1, in which a water-soluble whitening agent was added in addition to nicotinic acid amide.
On the other hand, the comparative products 1 and 2 containing no (B) anionic surfactant showed significant separation within 3 days in the stability test over time, and gave a sticky feeling during use. (C) Comparative Example 3, which does not contain a higher alcohol that is solid at 20° C., and Comparative Example 4, which uses isostearyl alcohol, which is a branched-chain saturated alcohol that is liquid at 20° C., were tested for stability over time. Noticeable separation was seen by the next day. (D) In Comparative Example 5 containing no gellan gum, precipitation of crystals was confirmed, and significant separation was observed within 3 days. (D) In Comparative Example 6, in which xanthan gum, which is a general-purpose thickening agent, was used instead of gellan gum, crystal precipitation and significant separation were observed within one week. (E) Crystal precipitation occurred in Comparative Example 7 in which the monohydric alcohol ethanol was blended instead of the polyhydric alcohol. In addition, almost no whitening effect was observed in Comparative Example 8, which does not contain nicotinic acid amide.
実施例13:水中油型日焼け止めクリーム
(成分) (質量%)
1.1,3-ブチレングリコール 12.0
2.ジグリセリン 3.0
3.精製水 適量
4.ニコチン酸アミド 6.0
5.パラオキシ安息香酸メチル 0.1
6.ステアリン酸スクロース 1.0
7.(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー
*4 0.1
8.ジェランガム *3 0.05
9.30%ジラウロイルグルタミン酸リシンNa水溶液 0.3
10.モノステアリン酸グリセリル 1.5
11.セスキオレイン酸ソルビタン 0.3
12.水添レシチン 0.1
13.ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル) 3.0
14.セチルリン酸ジエタノールアミン *5 0.5
15.メトキシケイヒ酸エチルヘキシル 5.0
16.ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 1.0
17.ホホバ油 5.0
18.シアバター 2.0
19.スクワラン 1.0
20.セラミド3 0.1
21.トコフェロール 0.05
22.セトステアリルアルコール 2.0
23.コレステロール 0.3
24.ユビキノン 0.001
25.水添ポリイソブテン 2.0
26.40%ポリアクリルアミド溶液 0.3
(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー *4 SEPINOV EMT10:セピック社製
セチルリン酸ジエタノールアミン*5 AMPHISOL:DSM ニュートリション社製
Example 13: Oil-in-water sunscreen cream (ingredient) (mass%)
1.1,3-butylene glycol 12.0
2. Diglycerin 3.0
3. Purified water Appropriate amount 4. Nicotinamide 6.0
5. Methyl paraoxybenzoate 0.1
6. Sucrose stearate 1.0
7. (Hydroxyethyl acrylate/Na acryloyldimethyltaurate) copolymer *4 0.1
8. Gellan gum *3 0.05
9.30% dilauroyl glutamate lysine Na aqueous solution 0.3
10. Glyceryl monostearate 1.5
11. Sorbitan sesquioleate 0.3
12. Hydrogenated lecithin 0.1
13. Di(phytosteryl/octyldodecyl) lauroyl glutamate 3.0
14. Diethanolamine cetyl phosphate *5 0.5
15. Ethylhexyl methoxycinnamate 5.0
16. Diethylaminohydroxybenzoyl hexyl benzoate 1.0
17. Jojoba oil 5.0
18. Shea butter 2.0
19. Squalane 1.0
20. Ceramide 3 0.1
21. Tocopherol 0.05
22. Cetostearyl alcohol 2.0
23. Cholesterol 0.3
24. Ubiquinone 0.001
25. Hydrogenated polyisobutene 2.0
26.40% polyacrylamide solution 0.3
(Hydroxyethyl acrylate/Na acryloyldimethyltaurate) copolymer *4 SEPINOV EMT10: diethanolamine cetyl phosphate manufactured by Seppic *5 AMPHISOL: manufactured by DSM Nutrition
(製造方法)
(a):成分1~9を70℃で均一に溶解混合する。
(b):成分10~25を80℃で均一に溶解混合する。
(c):(a)に(b)を添加し70℃で乳化する。
(d):(c)に26を加えて均一になるまで混合する。
(e):40℃まで冷却して水中油型日焼け止めクリームを得た。
(Production method)
(a): Components 1 to 9 are uniformly dissolved and mixed at 70°C.
(b): Components 10 to 25 are uniformly dissolved and mixed at 80°C.
(c): Add (b) to (a) and emulsify at 70°C.
(d): Add 26 to (c) and mix until uniform.
(e): Cooled to 40°C to obtain an oil-in-water sunscreen cream.
実施例13の水中油型日焼け止めクリームは、美白効果、ベタツキ、結晶析出抑制効果、経時安定性が優れた皮膚外用組成物であった。 The oil-in-water sunscreen cream of Example 13 was an external composition for skin with excellent whitening effect, stickiness, crystal precipitation suppressing effect, and long-term stability.
実施例14:水中油型乳化美容液
(成分) (質量%)
1.1,3-ブチレングリコール 5.0
2.ジプロピレングリコール 5.0
3.キシリトール 3.0
4.精製水 適量
5.ニコチン酸アミド 4.0
6.ジェランガム *3 0.1
7.92%(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー/(t-ブタノール/水混合品)*6 0.1
8.ヤシ油脂肪酸ポリオキシエチレンソルビタン(20E.O.) 0.5
9.マカデミアナッツ油脂肪酸フィトステリル 2.0
10.セタノール 3.0
11.ジメチルポリシロキサン(5CS) 3.0
12.ステアロイルグルタミン酸ナトリウム *2 0.2
13.ミリスチン酸ポリグリセリル-5 1.0
14.トコフェロール 0.1
15.グリチルレチン酸ステアリル 0.05
16.10%水酸化ナトリウム水溶液 0.5
17.フェノキシエタノール 0.2
18.エタノール 5.0
19.0.3%水溶性コラーゲン水溶液 0.1
20.1%ヒアルロン酸ナトリウム水溶液 0.1
21.シロキクラゲ多糖体 0.1
22.10%リン酸アスコルビルナトリウム水溶液 10.0
92%(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー (t-ブタノール/水混合品) *6 ARISTOFLEX AVC:クラリアント社製
Example 14: Oil-in-water emulsified beauty essence (ingredient) (mass%)
1.1,3-butylene glycol 5.0
2. Dipropylene glycol 5.0
3. Xylitol 3.0
4. Purified water Appropriate amount5. Nicotinamide 4.0
6. Gellan gum *3 0.1
7.92% (acryloyldimethyltaurate ammonium/VP) copolymer/(t-butanol/water mixture) *6 0.1
8. Coconut fatty acid polyoxyethylene sorbitan (20 E.O.) 0.5
9. Macadamia nut oil fatty acid phytosteryl 2.0
10. Cetanol 3.0
11. Dimethylpolysiloxane (5CS) 3.0
12. Sodium stearoyl glutamate *2 0.2
13. Polyglyceryl-5 myristate 1.0
14. Tocopherol 0.1
15. Stearyl glycyrrhetinate 0.05
16.10% sodium hydroxide aqueous solution 0.5
17. Phenoxyethanol 0.2
18. Ethanol 5.0
19.0.3% water-soluble collagen aqueous solution 0.1
20.1% sodium hyaluronate aqueous solution 0.1
21. Tremella fungus polysaccharide 0.1
22.10% sodium ascorbyl phosphate aqueous solution 10.0
92% (acryloyldimethyltaurate ammonium/VP) copolymer (t-butanol/water mixture) *6 ARISTOFLEX AVC: manufactured by Clariant
(製造方法)
(a):成分1~8を70℃で均一に溶解混合する。
(b):成分9~15を80℃で均一に溶解混合する。
(c):(a)に(b)を添加し70℃で乳化する。
(d):(c)を冷却開始後、45℃で成分18~22を順次添加した後、40℃まで冷却して水中油型乳化美容液を得た。
(Production method)
(a): Components 1 to 8 are uniformly dissolved and mixed at 70°C.
(b): Components 9 to 15 are uniformly dissolved and mixed at 80°C.
(c): Add (b) to (a) and emulsify at 70°C.
(d): After starting cooling of (c), components 18 to 22 were sequentially added at 45°C, and then cooled to 40°C to obtain an oil-in-water emulsified beauty essence.
実施例14の水中油型乳化美容液は、美白効果、ベタツキ、結晶析出抑制効果、経時安定性が優れた皮膚外用組成物であった。 The oil-in-water emulsified beauty essence of Example 14 was an external composition for skin with excellent whitening effect, stickiness, crystal precipitation suppressing effect, and long-term stability.
実施例15:水系保湿ジェル
(成分) (質量%)
1.1,2-ペンタンジオール 0.5
2.1,3-ブチレングリコール 12.0
3.メチルグルセスー10 3.0
4.37.5%(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー/イソヘキサデカン/ポリソルベート80/水混合品 *7 0.3
5.5%ポリクオタニウムー51水溶液 0.3
6.ジェランガム *3 0.05
7.(PEG-240/デシルテトラデセス-20/HDI)コポリマー *8
0.7
8.ニコチン酸アミド 3.0
9.トラネキサム酸 2.0
10.カルボマー 0.1
11.10%水酸化カリウム水溶液 1.0
12.セチルリン酸カリウム *2 0.2
13. セタノール 0.4
14.PEG-100水添ヒマシ油 0.5
15.エチルヘキシルグリセリン 0.3
16. 精製水 適量
37.5%(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー/イソヘキサデカン/ポリソルベート80/水混合品 *7 SIMULGEL EG QD:セピック社製
(PEG-240/デシルテトラデセス-20/HDI)コポリマー *8 アデカノールGT-700:アデカ社製
Example 15: Water-based moisturizing gel (component) (% by mass)
1.1,2-pentanediol 0.5
2.1,3-butylene glycol 12.0
3. Methyl gluceth-10 3.0
4.37.5% (Na acrylate/Na acryloyldimethyltaurate) copolymer/isohexadecane/polysorbate 80/water mixture *7 0.3
5.5% polyquaternium-51 aqueous solution 0.3
6. Gellan gum *3 0.05
7. (PEG-240/decyltetradeceth-20/HDI) copolymer *8
0.7
8. Nicotinamide 3.0
9. Tranexamic acid 2.0
10. Carbomer 0.1
11.10% potassium hydroxide aqueous solution 1.0
12. Potassium cetyl phosphate *2 0.2
13. Cetanol 0.4
14. PEG-100 hydrogenated castor oil 0.5
15. Ethylhexylglycerin 0.3
16. Purified water Appropriate amount
37.5% (Na acrylate/Na acryloyldimethyltaurate) copolymer/isohexadecane/polysorbate 80/water mixture *7 SIMULGEL EG QD: (PEG-240/decyltetradeceth-20/HDI) copolymer manufactured by Sepik * 8 Adekanol GT-700: manufactured by Adeka
(製造方法)
(a):あらかじめ成分12~14を加熱溶解しておく。
(b):成分15に(a)および、1~11の各成分を添加混合し透明均一になるまで攪拌し水系保湿ジェルを得た。
(Production method)
(a): Ingredients 12 to 14 are heated and dissolved in advance.
(b): To component 15, components (a) and each of components 1 to 11 were added and mixed, and the mixture was stirred until transparent and uniform to obtain a water-based moisturizing gel.
実施例15の水系保湿ジェルは、美白効果、ベタツキ、結晶析出抑制効果、経時安定性の優れた皮膚外用組成物であった。 The water-based moisturizing gel of Example 15 was an external composition for skin with excellent whitening effect, stickiness, crystal precipitation suppressing effect, and long-term stability.
実施例16:シートマスク(不織布含浸美容液)
(成分) (質量%)
1.1,2-ヘキサンジオール 0.5
2.1,3-ブチレングリコール 10.0
3.メチルグルセスー10 1.0
4.(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー
0.05
5.ジェランガム *3 0.1
6.キサンタンガム 0.2
7.PEG/PPG/ポリブチレングリコール-8/5/3グリセリン 0.3
8.ヒアルロン酸ナトリウム 0.01
9.ニコチン酸アミド 7.0
10.オクテニルコハク酸デンプンAl 0.5
11.グリチルリチン酸ジカリウム 0.1
12.グリセリン 5.0
13.セタノール 0.1
14.リン酸セチル *9 0.1
15.PPG-6デシルテトラデセス-30 0.5
16.エチルヘキシルグリセリン 0.2
17.メチルパラベン 0.1
18.精製水 適量
19・10%水酸化カリウム水溶液 0.2
リン酸セチル Hostaphat CC100 *9 クラリアント社製
Example 16: Sheet mask (Nonwoven fabric impregnated serum)
(Component) (% by mass)
1.1,2-hexanediol 0.5
2.1,3-butylene glycol 10.0
3. Methyl gluceth-10 1.0
4. (Acrylates/C10-30 alkyl acrylate) crosspolymer
0.05
5. Gellan gum *3 0.1
6. Xanthan gum 0.2
7. PEG/PPG/polybutylene glycol-8/5/3 glycerin 0.3
8. Sodium hyaluronate 0.01
9. Nicotinamide 7.0
10. Starch Octenyl Succinate Al 0.5
11. Dipotassium glycyrrhizinate 0.1
12. Glycerin 5.0
13. Cetanol 0.1
14. Cetyl phosphate *9 0.1
15. PPG-6 decyltetradeceth-30 0.5
16. Ethylhexylglycerin 0.2
17. Methylparaben 0.1
18. Purified water Appropriate amount 19.10% potassium hydroxide aqueous solution 0.2
Cetyl phosphate Hostaphat CC100 *9 manufactured by Clariant
(製造方法)
(a):あらかじめ成分12~17を加熱溶解しておく。
(b):成分18に(a)および、1~11の各成分を添加混合し均一になるまで攪拌し美容液を得た。
(c):(b)に19を入れて混合しシートマスク用原液とした。
(d):本美容液を、顔状に成形した不織布(500cm2,目付60g/m2,レーヨン/ポリプロピレン=70%/30%)に30g含浸させ、アルミシート袋に充填して、シートマスクを調整した。
(Production method)
(a): Ingredients 12 to 17 are heated and dissolved in advance.
(b): Component (a) and each of components 1 to 11 were added to component 18, mixed and stirred until uniform to obtain a beauty essence.
(c): 19 was added to (b) and mixed to prepare a stock solution for a sheet mask.
(d): Impregnate 30 g of this serum into a face-shaped non-woven fabric (500 cm2, basis weight 60 g/m2, rayon/polypropylene = 70%/30%), fill it in an aluminum sheet bag, and prepare a sheet mask. bottom.
実施例16のシートマスクは、美白効果、ベタツキ、使用時に結晶析出がない、経時安定性の優れたものであった。 The sheet mask of Example 16 had a whitening effect, no stickiness, no crystal deposition during use, and excellent stability over time.
実施例17:オールインワンゲル
(成分) (質量%)
1.リンゴ酸ジイソステアリル 1.0
2.ベヘニルアルコール 1.0
3.エチルヘキサン酸セチル 4.0
4.ジメチコン 1.5
5.スクワラン 4.0
6.ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル) 1.0
7.ココイルメチルタウリンナトリウム 1.0
8.セスキオレイン酸ソルビタン 0.8
9.ステアリン酸スクロース 2.0
10.ステアリン酸ポリグリセリル-10 1.5
11.PEG-50水添ヒマシ油 1.0
12.トコフェロール 0.1
13.水 適量
14.1,3-ブチレングリコール 10.0
15.ヒドロキシプロピルメチルセルロースステアロキシエーテル*10 0.1
16.グリセリン 15.0
17.カルボマー 0.1
18.ジェランガム *3 0.1
19.ブチルカルバミン酸ヨウ化プロピニル 0.003
20.エチルヘキシルグリセリン 0.2
21.ニコチン酸アミド 4.0
22.フェノキシエタノール 0.2
23.アルブチン 3.0
24.パルミチン酸レチノール/コーン油混合物 0.001
25.10%アルギニン水溶液 1.0
26.グルタミン酸ナトリウム 0.01
27.クレアチニン 0.01
28.ツボクサエキス 0.01
29.ハイビスカス花エキス 0.01
30.加水分解ヒアルロン酸 0.01
31.コンフリー葉エキス 0.01
32.加水分解エラスチン 0.01
33.加水分解ダイズタンパク 0.01
34.マンダリンオレンジ果皮エキス 0.01
35.乳酸桿菌/セイヨウナシ果汁発酵液 0.01
36.ハトムギ種子エキス 0.01
37.ゲットウ葉エキス 0.01
ヒドロキシプロピルメチルセルロースステアロキシエーテル *10 サンジェロース 60L:大同化成社製
Example 17: All-in-one gel (component) (mass%)
1. Diisostearyl malate 1.0
2. behenyl alcohol 1.0
3. Cetyl ethylhexanoate 4.0
4. Dimethicone 1.5
5. Squalane 4.0
6. Dimer dilinoleic acid (phytosteryl/isostearyl/cetyl/stearyl/behenyl) 1.0
7. Cocoyl methyl taurate sodium 1.0
8. Sorbitan sesquioleate 0.8
9. Sucrose stearate 2.0
10. Polyglyceryl-10 stearate 1.5
11. PEG-50 hydrogenated castor oil 1.0
12. Tocopherol 0.1
13. water appropriate amount 14.1,3-butylene glycol 10.0
15. Hydroxypropyl methylcellulose stearoxy ether *10 0.1
16. Glycerin 15.0
17. Carbomer 0.1
18. Gellan gum *3 0.1
19. Propynyl iodide butylcarbamate 0.003
20. Ethylhexylglycerin 0.2
21. Nicotinamide 4.0
22. Phenoxyethanol 0.2
23. Arbutin 3.0
24. Retinol palmitate/corn oil mixture 0.001
25.10% arginine aqueous solution 1.0
26. Sodium glutamate 0.01
27. Creatinine 0.01
28. Centella asiatica extract 0.01
29. Hibiscus flower extract 0.01
30. Hydrolyzed hyaluronic acid 0.01
31. Comfrey leaf extract 0.01
32. Hydrolyzed elastin 0.01
33. Hydrolyzed soy protein 0.01
34. Mandarin orange peel extract 0.01
35. Lactobacillus / pear juice fermentation liquid 0.01
36. Pearl barley seed extract 0.01
37. Alpinia purpurea leaf extract 0.01
Hydroxypropyl methylcellulose stearoxy ether *10 Sangelose 60L: manufactured by Daido Kasei Co., Ltd.
(製造方法)
(a):成分1~12を70℃で均一に溶解混合する。
(b):成分13~24を80℃で均一に溶解混合する。
(c):(b)に(a)を添加し70℃で乳化する。
(d):(c)を冷却開始後、45℃で成分25~37を順次添加した後、35℃まで冷却して水中油型乳化美容液を得た。
(Production method)
(a): Components 1 to 12 are uniformly dissolved and mixed at 70°C.
(b): Components 13 to 24 are uniformly dissolved and mixed at 80°C.
(c): (a) is added to (b) and emulsified at 70°C.
(d): After starting cooling of (c), components 25 to 37 were sequentially added at 45°C, and then cooled to 35°C to obtain an oil-in-water emulsified beauty essence.
実施例17のオールインワンゲルは、美白効果、ベタツキ、結晶析出抑制効果、経時安定性が優れた皮膚外用組成物であった。
The all-in-one gel of Example 17 was an external composition for skin with excellent whitening effect, stickiness, crystal precipitation suppressing effect, and long-term stability.
実施例18:水中油型乳化美容液(多種抽出物配合美容液)
(成分) (質量%)
1.1,3-ブチレングリコール 9.0
2.ジグリセリン 5.0
3.マルトース 3.0
4.精製水 適量
5.ニコチン酸アミド 4.0
6.ジェランガム *3 0.1
7.(ヒドロキシプロピルメチルセルロースステアロキシエーテル *10 0.1
8.PEG-50水添ヒマシ油 2.0
9.ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル) 2.0
10.ステアリルアルコール 1.0
11.水添ポリイソブテン 3.0
12.セチルリン酸カリウム *2 0.5
13.セスキオレイン酸ソルビタン 0.8
14.グリチルレチン酸ステアリル 0.05
15.トコフェロール 0.1
16.フェノキシエタノール 0.2
17.バラ抽出物 0.01
18.桜抽出物 0.01
19.ユリ抽出物 0.01
20.シマホオズキ抽出物 0.01
21.ガジュツ抽出物 0.01
22.茶抽出物 0.01
23.ジオウ抽出物 0.01
24.トウキ抽出物 0.01
25.ハイビスカス抽出物 0.01
26.トルメンチラ抽出物 0.01
27.バオバブ抽出物 0.01
28.イレイセン抽出物 0.01
29.ヒマワリ抽出物 0.01
30.クスリグサ抽出物 0.01
31.カンゾウ抽出物 0.01
32.ベニバナ抽出物 0.01
33.朝鮮人参抽出物 0.01
34.ハトムギ抽出物 0.01
35.スギナ抽出物 0.01
36.イチョウ抽出物 0.01
37.ホホバ抽出物 0.01
38.テルミナリア抽出物 0,01
39.ハコベ抽出物 0.01
40.トウモロコシ抽出物 0.01
41.ハナイグチ抽出物 0.01
42.ザクロ抽出物 0.01
43.メシマコブ抽出物 0.01
44.ローズヒップ抽出物 0.01
45.月見草抽出物 0.01
46.カミツレ抽出物 0.01
47.ダイズ抽出物 0.01
48.シロハナマメ抽出物 0.01
49.ミカン抽出物 0.01
50.モクテンリョウ抽出物 0.01
51.黒ニンジン抽出物 0.01
52.ホワイトストロベリー抽出物 0.01
53.ヒマラヤンラズベリー抽出物 0.01
54.ネムノキ抽出物 0.01
55.スイートマジョラム抽出物 0.01
56.モダマ抽出物 0.01
57.コンフリー葉エキス 0.01
58.サッカロミセス/デイリリー花発酵液 0.01
59.ゲットウ葉エキス 0.01
60.ムラサキシキブ果実エキス 0.01
61.ヒバマタエキス 0.01
62.加水分解ダイズタンパク 0.01
63.タベブイアインペチギノサ樹皮エキス 0.01
64.グルコシルヘスペリジン 0.01
Example 18: Oil-in-water emulsified beauty essence (multiple extract-containing beauty essence)
(Component) (% by mass)
1.1,3-butylene glycol 9.0
2. Diglycerin 5.0
3. Maltose 3.0
4. Purified water Appropriate amount5. Nicotinamide 4.0
6. Gellan gum *3 0.1
7. (Hydroxypropyl methylcellulose stearoxy ether *10 0.1
8. PEG-50 hydrogenated castor oil 2.0
9. dimer dilinoleic acid (phytosteryl/isostearyl/cetyl/stearyl/behenyl) 2.0
10. Stearyl alcohol 1.0
11. Hydrogenated polyisobutene 3.0
12. Potassium cetyl phosphate *2 0.5
13. Sorbitan sesquioleate 0.8
14. Stearyl glycyrrhetinate 0.05
15. Tocopherol 0.1
16. Phenoxyethanol 0.2
17. Rose extract 0.01
18. Sakura extract 0.01
19. Lily extract 0.01
20. Shimahozuki extract 0.01
21. zedoary extract 0.01
22. Tea extract 0.01
23. Rhubarb extract 0.01
24. Angelica extract 0.01
25. Hibiscus extract 0.01
26. Tormentilla extract 0.01
27. Baobab extract 0.01
28. Ireisen extract 0.01
29. Sunflower extract 0.01
30. Kusuri extract 0.01
31. Glycyrrhiza extract 0.01
32. Safflower extract 0.01
33. Ginseng extract 0.01
34. Hatomugi extract 0.01
35. horsetail extract 0.01
36. Ginkgo biloba extract 0.01
37. Jojoba extract 0.01
38. Terminalia extract 0,01
39. Chickweed extract 0.01
40. Corn extract 0.01
41. Honeycomb extract 0.01
42. Pomegranate extract 0.01
43. Phellinus linteus extract 0.01
44. Rosehip extract 0.01
45. Evening primrose extract 0.01
46. Chamomile extract 0.01
47. Soybean extract 0.01
48. White bean extract 0.01
49. Mandarin orange extract 0.01
50. Magnolia extract 0.01
51. Black carrot extract 0.01
52. White strawberry extract 0.01
53. Himalayan raspberry extract 0.01
54. Silk tree extract 0.01
55. Sweet marjoram extract 0.01
56. Modama extract 0.01
57. Comfrey leaf extract 0.01
58. Saccharomyces/day lily flower fermentation liquid 0.01
59. Alpinia purpurea leaf extract 0.01
60. Murasakishibu fruit extract 0.01
61. Fucus extract 0.01
62. Hydrolyzed soy protein 0.01
63. Tabebuia impetiginosa bark extract 0.01
64. Glucosyl hesperidin 0.01
(製造方法)
(a):成分1~7を70℃で均一に溶解混合する。
(b):成分8~16を80℃で均一に溶解混合する。
(c):(a)に(b)を添加し70℃で乳化する。
(d):(c)を冷却開始後、45℃で成分17~64を順次添加した後、35℃まで冷却して水中油型乳化美容液を得た。
(Production method)
(a): Components 1 to 7 are uniformly dissolved and mixed at 70°C.
(b): Components 8 to 16 are uniformly dissolved and mixed at 80°C.
(c): Add (b) to (a) and emulsify at 70°C.
(d): After starting cooling of (c), components 17 to 64 were sequentially added at 45°C, and then cooled to 35°C to obtain an oil-in-water emulsified beauty essence.
実施例18の水中油型乳化美容液は、美白効果、ベタツキ、結晶析出抑制効果、経時安定性が優れた皮膚外用組成物であった。 The oil-in-water emulsified beauty essence of Example 18 was a composition for external use on the skin that was excellent in whitening effect, stickiness, effect of suppressing crystal precipitation, and stability over time.
本発明は、化粧料、医薬部外品、皮膚外用剤等に適用できる。
INDUSTRIAL APPLICABILITY The present invention can be applied to cosmetics, quasi-drugs, external preparations for skin, and the like.
Claims (4)
(A)ニコチン酸アミド:1~10質量%
(B)アニオン性界面活性剤
(C)20℃で固体状の高級アルコール
(D)ジェランガム
(E)多価アルコール:5~25質量%
を含む水中油型乳化組成物。 the following components (A) to (E);
(A) Nicotinamide: 1 to 10% by mass
(B) Anionic surfactant (C) Higher alcohol solid at 20°C (D) Gellan gum (E) Polyhydric alcohol: 5 to 25 mass%
An oil-in-water emulsion composition comprising:
(E)/(A)≧2である請求項1記載の水中油型乳化組成物。 The blending mass ratio of component (E) and component (A) is
2. The oil-in-water emulsion composition according to claim 1, wherein (E)/(A)≧2.
4. The oil-in-water emulsion composition according to any one of claims 1 to 3, wherein the water-soluble whitening agent of component (F) is one or more selected from ascorbic acid derivatives and salts thereof, tranexamic acid, and arbutin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021213602A JP2023097474A (en) | 2021-12-28 | 2021-12-28 | Oil-in-water emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021213602A JP2023097474A (en) | 2021-12-28 | 2021-12-28 | Oil-in-water emulsion composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023097474A true JP2023097474A (en) | 2023-07-10 |
Family
ID=87071761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021213602A Pending JP2023097474A (en) | 2021-12-28 | 2021-12-28 | Oil-in-water emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023097474A (en) |
-
2021
- 2021-12-28 JP JP2021213602A patent/JP2023097474A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1600143B1 (en) | SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE | |
JP5432470B2 (en) | Ceramide solution and external preparation for skin | |
JP5180556B2 (en) | Skin external preparations and cosmetics containing ubiquinone derivatives or salts thereof, and methods of use thereof | |
JP2008231010A (en) | External preparation for skin | |
JP7374755B2 (en) | Skin external composition | |
JP6367003B2 (en) | Oil-in-water emulsified cosmetic | |
JP2013107862A (en) | Skin cosmetic gel | |
JP2012017318A (en) | Liquid crystal and skin external preparation containing the same | |
JP4902212B2 (en) | Cosmetic composition and method for producing the same | |
JP2005281133A (en) | Skin care preparation for external use | |
JP5393998B2 (en) | Milky liquid cosmetics | |
JP2005132828A (en) | Composition for external application | |
WO2017179356A1 (en) | Superfatting agent and personal care composition | |
JP2023097474A (en) | Oil-in-water emulsion composition | |
JP2004123575A (en) | Gel-like composition for external use | |
JP6545953B2 (en) | Emulsion-type external skin preparation | |
JP2005336156A (en) | Skin preparation for external use comprising salt of ascorbic acid derivative, stabilizing method of skin preparation for external use, and stabilizer | |
JP2000034219A (en) | Preparing for external use for skin | |
JP2001131016A (en) | Composition for external use | |
JP2017081883A (en) | External preparation for skin | |
KR20160071744A (en) | Thermo-sensitive color cosmetic composition and the method of producing the same | |
JP2022138175A (en) | External composition for skin | |
JP2019077675A (en) | Gel-like external preparation for skin and skin cosmetic | |
JP2020015677A (en) | External composition containing cholesterol and/or phytosterol | |
JP2013256472A (en) | Thickening composition containing acylated amino acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211228 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240501 |